23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients

Advanced therapies have ground-breaking therapeutic potential for patients, including in currently underserved areas, bringing the possibility of a cure to life-threatening conditions with a one-off treatment.
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders

EuropaBio is pleased to announce that Disc Medicine has joined as a corporate member.
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?

01/03/2023

Vlad Olteanu new Healthcare Public Affairs Director at EuropaBio

28/02/2023

Helping Europe Deliver for Rare Disease Patients

06/02/2023

Delivering Europe’s ambitions in rare disease

31/01/2023

EuropaBio’s 2022 Patient BioForum sets out recommendations to address the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

17/01/2023

EuropaBio launches SME BioForum in Rare Diseases

16/01/2023

SwiftPharma joins EuropaBio: pioneering sustainable, scalable and affordable plant-made therapeutic proteins

19/12/2022

EuropaBio sat down with new member Association of Biotechnological Companies Bioforum, to find out how they champion biotech in central and eastern Europe

19/12/2022

The Association of Biotechnological Companies Bioforum joins EuropaBio: representing Polish biotech at European legislative fora and involving Polish companies in the debate about the future of the industry

13/12/2022

EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
13/12/2022

EuropaBio sat down with new member SenseUp, to find out about the natural evolution approach for novel protein and RNA products

13/12/2022

SenseUp joins EuropaBio: leveraging the power of bio-tech for sustainable and commercially viable solutions

08/12/2022

‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework

European Industry trade and supply chain needs to respond to Covid-19 - Joint Letter to the EU Trade Ministers.
23/11/2022

Innovation, Investment, and Excellence for Healthcare Biotechnology: Achieving a competitive environment in Europe | EuropaBio Healthcare BioForum, October 2022

EuropaBio hosted its inaugural Healthcare BioForum on October 5, 2022. The roundtable brought together representatives from SMEs, large companies, DGs GROW, Santé and RTD, European Parliament and Member States to discuss links between innovation, investment, and excellence in European healthcare biotechnology.
11/11/2022

The Revision of the Orphan Medicines Regulation Is an Opportunity. Will Europe Seize it?

24/10/2022

European Biotech Week 2022: Bringing Biotech to Local Communities